Expression of β-adrenoceptor subtypes in urothelium, interstitial cells and detrusor of the human urinary bladder

LUTS: Lower Urinary Tract Symptoms

Volumn 5, Issue 3, 2013, Pages 173-180

  Otsuka, Atsushi ^a   Kawasaki, Hideya ^a   Matsumoto, Rikiya ^a   Shinbo, Hitoshi ^b   Kurita, Yutaka ^b   Iwashita, Toshihide ^a   Ozono, Seiichiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Enshu Hospital   (Japan)

Author keywords

3 adrenoceptor; Detrusor muscle; Myofibroblast; Suburothelium; Urothelium

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; VIMENTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DETRUSOR MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CELL OF CAJAL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TISSUE DISTRIBUTION; UROTHELIUM;

EID: 84882989788     PISSN: 17575664     EISSN: 17575672     Source Type: Journal    
DOI: 10.1111/luts.12007     Document Type: Article

References (33)

1. 3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 1999; 288: 1367-73.
2. 3- adrenoceptor in the human detrusor muscle. Br J Pharmacol 1999; 126: 819-25.
3. 3- adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 2007; 321: 642-7.
4. 3- adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study. Int J Urol 2008; 15: 1072-6.
5. Chapple CR, Yamaguchi O, Ridder A et al. Clinical proof of concept study (BLOSSOM) shows novel β3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder. Eur Urol Suppl 2008; 7: 239.
6. Sui GP, Rothery S, Dupont E, Fry CH, Severs NJ. Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int 2002; 90: 118-29.
7. Wiseman OJ, Fowler CJ, Landon DN. The role of the human bladder lamina propria myofibroblast. BJU Int 2003; 91: 89-93.
8. Davidson RA, McCloskey KD. Morphology and localization of interstitial cells in the guinea pig bladder: structural relationships with smooth muscle and neurons. J Urol 2005; 173: 1385-90.
9. Brading AF, McCloskey KD. Mechanisms of disease: specialized interstitial cells of the urinary tract-an assessment of current knowledge. Nat Clin Pract Urol 2005; 2: 546-54.
10. McCloskey KD. Interstitial cells in the urinary bladder- localization and function. Neurourol Urodyn 2010; 29: 82-7.
11. Fry CH, Ikeda Y, Harvey R, Wu C, Sui GP. Control of bladder function by peripheral nerves: avenues for novel drug targets. Urology 2004; 63: 24-31.
12. De Groat WC. The urothelium in overactive bladder: passive bystander or active participant? Urology 2004; 64: 7-11.
13. 3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 2006; 176: 367-73.
14. Sui GP, Wu C, Fry CH. Characterization of the purinergic receptor subtype on guinea-pig suburothelial myofibroblasts. BJU Int 2006; 97: 1327-31.
15. Liu F, Takahashi N, Yamaguchi O. Expression of P2X3 purinoceptors in suburothelial myofibroblasts of the normal human urinary bladder. Int J Urol 2009; 16: 570-5.
16. McCloskey KD, Gurney AM. Kit positive cells in the guinea pig bladder. J Urol 2002; 168: 832-6.
17. Wu C, Sui GP, Fry CH. Purinergic regulation of guinea pig suburothelial myofibroblasts. J Physiol 2004; 559: 231-43.
18. Limberg BJ, Andersson KE, Kullmann AF, Burmer G, de Groat WC, Rosenbaum JS. β-Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder. Cell Tissue Res 2010; 342: 295-306.
19. Michel MC, Wieland T, Tsujimoto G. How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 385-8.
20. Pradidarcheep W, Stallen J, Labruyère WT, Dabhoiwala NF, Michel MC, Lamers WH. Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 397-402.
21. Hamdani N, van der Velden J. Lack of specificity of antibodies directed against human beta-adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 403-7.
22. Kullmann FA, Downs TR, Artim DE et al. Urothelial beta-3 adrenergic receptors in the rat bladder. Neurourol Urodyn 2011; 30: 144-50.
23. 3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol Urodyn 2010; 29: 1320-5.
24. Otsuka A, Shinbo H, Matsumoto R, Kurita Y, Ozono S. Expression and functional role of β-adrenoceptors in the human urinary bladder urothelium. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 473-81.
25. Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of α1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 2003; 170: 649-53.
26. 3-adrenoceptors in man. J Pharmacol Exp Ther 2009; 328: 213-22.
27. Roosen A, Datta SN, Chowdhury RA et al. Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment. Eur Urol 2009; 55: 1440-9.
28. Xue L, Li Y, Han X et al. Investigation of hyperpolarization-activated cyclic nucleotide-gated channels in interstitial cells of Cajal of human bladder. Urology 2012; 80: 224.e13-8.
29. 3 muscarinic receptor expression on suburothelial interstitial cells. BJU Int 2009; 104: 398-405.
30. Rahnama'i MS, van Koeveringe GA, Essers PB et al. Prostaglandin receptor EP1 and EP2 site in guinea pig bladder urothelium and lamina propria. J Urol 2010; 183: 1241-7.
31. Rasmussen H, Hansen A, Smedts F, Rumessen JJ, Horn T. CD34-positive interstitial cells of the human detrusor. APMIS 2007; 115: 1260-6.
32. 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 2010; 29: 771-6.
33. 3-adrenergic receptor agonists and botulinum toxin type-A. Neurourol Urodyn 2011; 30: 684-91.